NEFL and Parkinson disease: In two independent studies, Aamodt et al. [106] and Buhmann et al. [108] measured circulating NF-L levels in individuals with PD at different disease stages and found that NF-L levels varied according to the UPDRS III (Unified Parkinson’s Disease Rating Scale, Part III) score.